The pleasure I experience in reading this special issue of Pain Medicine, co-edited so capably by Drs. Bob Kerns and Steve Dobscha, comes not just from the intellectual stimulation of the studies themselves. As a now senior professional in pain medicine, just by reading the table of contents I immediately appreciate the cross-disciplinary academic breadth and quality of the research herein, and the progress we have made over the years. The titles represent traditional domains of our exciting biomedical enterprise, such as modulation of molecular mechanisms, gene therapies, symptom and psychophysiologic measurement, and the epidemiology of disease and illness. However, there are also articles in domains of relevance to our national debate on the organization of health care services, for example, in the sociomedical sciences such as studies of provider and practice factors, barriers to care, and the culture of medicine. If I reflect on where we started several decades ago, we should gain satisfaction in how far our research enterprise has progressed.
Pain medicine is really the first specialty to operationally fully embrace the biopsychosocial model in its scientific and clinical enterprise, as George Engel intended; not just brain-mind as in psychiatry and behavioral neuroscience, or bodybrain as in neurology, but how the dynamic relationship of mind, brain, and body interacts longitudinally with the environment to influence the course and outcome of pain and pain disorders and diseases. Long before cardiology "discovered" the severe impact of depression on outcomes of cardiac disease and the impact of behaviors on cardiac disease, pain clinicians had translated pain science into clinical teams with a strong biobehavioral clinical enterprise. Pain medicine emerged as a specialty fundamentally defined by the biopsychosocial model, its science and practice conceptually justified by the gate theory of pain perception. Note that in the Veterans Health Administration (VHA), the predominate practice model continues to be biopsychosocial, whereas because of provider economic incentives, outside the VHA pain medicine is increasingly dominated by a conceptually and evidence-challenged procedure-based practice without performancebased justification, and at high cost. The pain specialists' dilemma reflects the larger problem for all of American medicine-which economically punishes the provider who spends time and effort working with his or her patients to achieve the best decisions and health outcomes. For pain medicine specialists who wish to practice biopsychosocial medicine, the VHA has become an attractive place to practice and do research-and more are signing on. For psychologists and nurses and other professionals wishing to expand their opportunities for practice and scholarly work, the VHA is the place to be. Our mission is to improve the health outcomes of our veterans. The American health is system is beset with competing systems that wish to sustain profitability; because of these pressures they often lose sight of the public health mission to develop an efficient and cost-effective system of care for the public at large.
To this end, our Guest Editors Kerns and Dobscha recount the development of biopsychosocial pain research in the VHA as reflected in this special issue. Their tale demonstrates how a small, motivated group representing several intellectual disciplines, when organizationally supported and when focused by effective longitudinal leadership, can work collectively over far distances and at little cost to accomplish much in a large health system. What characterizes this research, and differentiates it from much of pain treatment research today outside the VHA, is that this research is not about products but about the nature of pain and pain disorders, the patients suffering from pain, and the system that cares for these patients. The incentives are provided by the pleasures of engaging in the scientific enterprise: the support of collaborators working together to help solve thorny problems, the fun of teamwork and intellectual exchange, the stable support of the system, the thrill of emerging findings, and the satisfaction that comes from doing things well while contributing to the improvement of the enterprise to benefit patients. It is worth considering the ingredients of VHA's successes in doing more with less, and the lessons learned that may help the larger U.S. health care system as it debates how to provide better, more efficient pain care for the rest of society.
Note that virtually all of this research is by university-affiliated investigators. As a young faculty member with research interests, the VA research environment has many advantages. Stable salaries and benefits enable investigators to weather funding lapses. Research subjects are readily available in a stable health care system with an integrated medical record. Large databases with pertinent data such as diagnoses, laboratory, radiographic, demographic, treatment, clinical outcomes, and costs are electronically available to enterprising investigators. Longitudinally stable infrastructures have developed to support these databases and to help investigators learn how to access them. These infrastructures are staffed by capable professionals who are dedicated to helping others do their research. The Pain Research Working Group has connected investigators to these resources and to project officers within the VHA at HSR&D and RR&D, facilitating the development of their research.
Unlike university clinical research outside the VHA, providers in the VHA are incentivized to work collectively towards health system goals rather than income generation through industry contracts. Thus, although many industry studies are also done through the VHA because of the availability of well-described defined disease/ condition cohorts, health services research is inherently valued in the VHA because of its longitudinal contribution to policy such as systems redesign for improved efficiency. While NIH dollars specifically targeted to clinical research in pain have been tiny relative to the massive costs of chronic pain in society, particularly health services research, the VHA has focused since 1998 on building its pain research infrastructure.
The first step in this direction occurred when the VHA designated a National Pain Management Strategy Coordinating Committee chaired by Jane Tollett. The Pain Research Working Group of the VA's National Pain Management Strategy Coordinating Committee emerged from this infrastructure, led by Dr. Kerns who over the past 5 years conducted almost monthly phone meetings supplemented by regular Internet communication. In 2008, the VHA formally designated and funded a National Pain Management Program Office for VHA headed by Dr. Kerns, to pursue this enterprise more formally. Pam Cremo and I have recently joined this office, and the PRIME center for the development of pain research, mentioned in the accompanying editorial, is another important step forward. The result of this development has been the creation of a culture of mutual support and intellectual networking, particularly important for new investigators. The enterprise is not dependent on the support of the massive industry funding that has generated other pain research collectives that are subject to downturns in the economy. It is not hamstrung as much by the competition for scarce funds that inhibits larger enterprise and leads to duplication of effort without large returns. In fact, networking across systems is rewarded by improving ones competitiveness for funding in the VHA. Ironically, our first face-to-face meeting was funded in 2006 by a small industry seed grant from the Pfizer epidemiology research office, who perceived the value of what we wanted to do for science and were totally independent of Pfizer's drug development or marketing divisions. We are very grateful. This meeting helped connect me and other investigators new to the VHA to key departments in the VHA Office of Research and led to the funding of several pain research projects related to the current OEF-OIF conflict.
The end result of the pain research working group has been the steady development of a greatly expanded pain research portfolio with a particularly important contribution to the health services research that is needed by our American health system. The scope of that science is demonstrated in this special issue of Pain Medicine, in earlier articles in Pain Medicine and other journals, and in recent issues of the most competitive journals such as JAMA (Drs. Dobscha and Bair). Our congratulations to our Guest Editors and the authors for this important contribution, marking the success of their work for our patients and the field. Not only will their science contribute to better care for the hundreds of thousands of troops returning with injuries from the present war, but also, they will help us transform pain care for all Americans.
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